Antrafenine

This classification denotes an anesthetic agent with the molecular formula C30H26F6N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 21FS93Y6OE, chemically known as 2-(4-(alpha,alpha,alpha-trifluoro-m-tolyl)-1-piperazinyl)ethyl n-(7-(trifluoromethyl)-4-quinolyl)anthranilate but generally known as antrafenine, which bears US NIH Compound Identifier 68723. European Medicines Agency schedules Antrafenine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05530MIG. The term ANTRAFENINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). ANTRAFENINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule antrafenine under HS 29335995 and SITC 51576. As of Q4 2014, ANTRAFENINE remains the US FDA Preferred Term for this commodity. Antrafenine bears US NLM identifiers UMLS ID C0052135 and NCI Concept Code C72107. SMILES: FC(F)(F)C1CC(N2CCN(CC2)CCOC(=O)C2C(NC3C4C(NCC3)CC(CC4)C(F)(F)F)CCCC2)CCC1.